If you’ve been diagnosed with mesothelioma, clinical trials may provide a way for you to access new, innovative treatments that aren’t yet available in other settings. All emerging therapies go through years of extensive testing before they’re approved for use; once they’re considered safe, clinical trials are conducted to evaluate their effectiveness. If a trial shows that a treatment is more effective than other comparable options, it may be approved for clinical use.
At Moffitt Cancer Center, we believe that clinical trials hold the key to a mesothelioma cure. Although no treatment has yet emerged as a definitive cure, every clinical trial brings us one step closer to that goal.
Thanks to our robust research program, we’ve identified a number of mesothelioma treatments that have helped our patients improve their quality of life. Many of our current trials focus on the following treatments:
- Immunotherapy
- Gene therapy
- Minimally invasive and robotic surgeries
- Targeted therapies
- Heated chemotherapy
In our Mesothelioma Research and Treatment Program, these trials are available alongside traditional treatments, such as radiation therapy and surgery. If you qualify for and choose to participate in a trial, you will do so under the supervision of our experienced oncologists. While you are enrolled in a trial, a multispecialty team will monitor your response to the treatment(s), making any necessary adjustments to your individualized treatment plan to ensure that you’re receiving the maximum benefits with the fewest side effects.
To see if you are eligible for one of our mesothelioma clinical trials, call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online. No referral is required.
